Stock Events

Stock Events

Lucid Diagnostics 

$0.9395
62
-$0.01-1.23% Friday 20:00
-$0.01-1.01%Friday 23:30After hours

Statistics

Day High
0.9372
Day Low
0.9344
52W High
1.629
52W Low
0.861
Volume
7,631
Avg. Volume
-
Mkt Cap
179.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.19
-0.15
-0.1
-0.06
Expected EPS
-0.0575
Actual EPS
N/A

Financials

-1,499.55%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.71MRevenue
-70.57MNet Income

Analyst Ratings

4.25Average Price Target
The highest estimate is 9.50.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LUCD. It's not an investment recommendation.
Tesla
11
TSLA
Lucid Group
11
LCID
Apple
9
AAPL
Amazon
9
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing in the broader cancer detection market alongside Lucid Diagnostics.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics offers comprehensive genetic testing, competing in the diagnostics market where Lucid Diagnostics operates.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics specializes in genetic testing and personalized medicine, including for cancer, competing with Lucid Diagnostics' offerings.
QuidelOrtho
QDEL
Mkt Cap1.01B
QuidelOrtho provides diagnostic testing solutions, including for cancer, competing in the same market as Lucid Diagnostics.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics offers broad diagnostic testing services, including for cancer, making it a competitor in the healthcare diagnostics field.
Labcorp
LH
Mkt Cap22.7B
LabCorp provides comprehensive clinical laboratory services, including cancer diagnostics, competing with Lucid Diagnostics.
Opko Health
OPK
Mkt Cap1.1B
OPKO Health, through its BioReference Laboratories, offers diagnostic and genomic testing services, including for cancer, competing in the diagnostics market.

About

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Show more...
CEO
Lishan Aklog
Employees
82
Country
United States
ISIN
US54948X1090

Listings

BOATS
BOATS
LUCD.BOATS
XNAS
US
LUCD

0 Comments

Share your thoughts

FAQ

What is Lucid Diagnostics stock price today?▼
The current price of LUCD is $0.94 USD — it has decreased by -1.23% in the past 24 hours. Watch Lucid Diagnostics stock price performance more closely on the chart.
What is Lucid Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lucid Diagnostics stocks are traded under the ticker LUCD.
Is Lucid Diagnostics stock price growing?▼
LUCD stock has fallen by -5.24% compared to the previous week, the month change is a -6.05% fall, over the last year Lucid Diagnostics has showed a -31.42% decrease.
What is Lucid Diagnostics market cap?▼
Today Lucid Diagnostics has the market capitalization of 179.4M
When is the next Lucid Diagnostics earnings date?▼
Lucid Diagnostics is going to release the next earnings report on November 16, 2026.
What were Lucid Diagnostics earnings last quarter?▼
LUCD earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.06 USD resulting in a -5.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lucid Diagnostics revenue for the last year?▼
Lucid Diagnostics revenue for the last year amounts to 4.71M USD.
What is Lucid Diagnostics net income for the last year?▼
LUCD net income for the last year is -70.57M USD.
How many employees does Lucid Diagnostics have?▼
As of September 05, 2026, the company has 82 employees.
In which sector is Lucid Diagnostics located?▼
Lucid Diagnostics operates in the Health & Wellness sector.
When did Lucid Diagnostics complete a stock split?▼
Lucid Diagnostics has not had any recent stock splits.
Where is Lucid Diagnostics headquartered?▼
Lucid Diagnostics is headquartered in NEW YORK, United States.